Early Aubagio ‘preferable for preventing disease progression’
Early Aubagio reduces disability progression more significantly than delayed treatment in patients with multiple sclerosis (MS), according to results from the phase three TOWER study and its open-label extension phase, presented at the 2015 Annual Meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)... Read more - http://www.ms-uk.org/MSnews
Early Aubagio ‘preferable for preventing disease progression
Early Aubagio ‘preferable for preventing disease progression
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2506 Views
-
Last post by NHE
-
- 0 Replies
- 1224 Views
-
Last post by frodo
-
- 0 Replies
- 1119 Views
-
Last post by NHE
-
- 0 Replies
- 1322 Views
-
Last post by frodo
-
- 0 Replies
- 1462 Views
-
Last post by NHE
-
- 0 Replies
- 1196 Views
-
Last post by frodo
-
- 0 Replies
- 1528 Views
-
Last post by NHE
-
- 0 Replies
- 1810 Views
-
Last post by DIM
-
- 0 Replies
- 1451 Views
-
Last post by NHE